Global Infectious Disease Testing Market Research Report 2024(Status and Outlook)
Report Overview
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
This report provides a deep insight into the global Infectious Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Disease Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Disease Testing market in any manner.
Global Infectious Disease Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Diagnostics
Abbott
Beckman Coulter Diagnostics
Roche
Siemens Healthcare
Abaxis
Acon Laboratories
Avioq
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Life Technologies
Maxim Biomedical
Market Segmentation (by Type)
by Technology
Immunodiagnostics
Clinical Microbiology
PCR
INAAT
DNA Sequencing & NGS
DNA Microarrays
Other
Market Segmentation (by Application)
Hospitals/Clinical Laboratories
Reference Laboratories
Academic/Research Institutes
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
This report provides a deep insight into the global Infectious Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Disease Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Disease Testing market in any manner.
Global Infectious Disease Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Diagnostics
Abbott
Beckman Coulter Diagnostics
Roche
Siemens Healthcare
Abaxis
Acon Laboratories
Avioq
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Life Technologies
Maxim Biomedical
Market Segmentation (by Type)
by Technology
Immunodiagnostics
Clinical Microbiology
PCR
INAAT
DNA Sequencing & NGS
DNA Microarrays
Other
Market Segmentation (by Application)
Hospitals/Clinical Laboratories
Reference Laboratories
Academic/Research Institutes
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Infectious Disease Testing Market
- Overview of the regional outlook of the Infectious Disease Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Infectious Disease Testing
1.2 Key Market Segments
1.2.1 Infectious Disease Testing Segment by Type
1.2.2 Infectious Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Disease Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Infectious Disease Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Infectious Disease Testing Sales by Manufacturers (2019-2024)
3.2 Global Infectious Disease Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Infectious Disease Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Infectious Disease Testing Sales Sites, Area Served, Product Type
3.6 Infectious Disease Testing Market Competitive Situation and Trends
3.6.1 Infectious Disease Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Infectious Disease Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Infectious Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease Testing Sales Market Share by Type (2019-2024)
6.3 Global Infectious Disease Testing Market Size Market Share by Type (2019-2024)
6.4 Global Infectious Disease Testing Price by Type (2019-2024)
7 INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease Testing Market Sales by Application (2019-2024)
7.3 Global Infectious Disease Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
8 INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY REGION
8.1 Global Infectious Disease Testing Sales by Region
8.1.1 Global Infectious Disease Testing Sales by Region
8.1.2 Global Infectious Disease Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Infectious Disease Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Infectious Disease Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Infectious Disease Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Infectious Disease Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Infectious Disease Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Diagnostics
9.1.1 Abbott Diagnostics Infectious Disease Testing Basic Information
9.1.2 Abbott Diagnostics Infectious Disease Testing Product Overview
9.1.3 Abbott Diagnostics Infectious Disease Testing Product Market Performance
9.1.4 Abbott Diagnostics Business Overview
9.1.5 Abbott Diagnostics Infectious Disease Testing SWOT Analysis
9.1.6 Abbott Diagnostics Recent Developments
9.2 Abbott
9.2.1 Abbott Infectious Disease Testing Basic Information
9.2.2 Abbott Infectious Disease Testing Product Overview
9.2.3 Abbott Infectious Disease Testing Product Market Performance
9.2.4 Abbott Business Overview
9.2.5 Abbott Infectious Disease Testing SWOT Analysis
9.2.6 Abbott Recent Developments
9.3 Beckman Coulter Diagnostics
9.3.1 Beckman Coulter Diagnostics Infectious Disease Testing Basic Information
9.3.2 Beckman Coulter Diagnostics Infectious Disease Testing Product Overview
9.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Product Market Performance
9.3.4 Beckman Coulter Diagnostics Infectious Disease Testing SWOT Analysis
9.3.5 Beckman Coulter Diagnostics Business Overview
9.3.6 Beckman Coulter Diagnostics Recent Developments
9.4 Roche
9.4.1 Roche Infectious Disease Testing Basic Information
9.4.2 Roche Infectious Disease Testing Product Overview
9.4.3 Roche Infectious Disease Testing Product Market Performance
9.4.4 Roche Business Overview
9.4.5 Roche Recent Developments
9.5 Siemens Healthcare
9.5.1 Siemens Healthcare Infectious Disease Testing Basic Information
9.5.2 Siemens Healthcare Infectious Disease Testing Product Overview
9.5.3 Siemens Healthcare Infectious Disease Testing Product Market Performance
9.5.4 Siemens Healthcare Business Overview
9.5.5 Siemens Healthcare Recent Developments
9.6 Abaxis
9.6.1 Abaxis Infectious Disease Testing Basic Information
9.6.2 Abaxis Infectious Disease Testing Product Overview
9.6.3 Abaxis Infectious Disease Testing Product Market Performance
9.6.4 Abaxis Business Overview
9.6.5 Abaxis Recent Developments
9.7 Acon Laboratories
9.7.1 Acon Laboratories Infectious Disease Testing Basic Information
9.7.2 Acon Laboratories Infectious Disease Testing Product Overview
9.7.3 Acon Laboratories Infectious Disease Testing Product Market Performance
9.7.4 Acon Laboratories Business Overview
9.7.5 Acon Laboratories Recent Developments
9.8 Avioq
9.8.1 Avioq Infectious Disease Testing Basic Information
9.8.2 Avioq Infectious Disease Testing Product Overview
9.8.3 Avioq Infectious Disease Testing Product Market Performance
9.8.4 Avioq Business Overview
9.8.5 Avioq Recent Developments
9.9 BD
9.9.1 BD Infectious Disease Testing Basic Information
9.9.2 BD Infectious Disease Testing Product Overview
9.9.3 BD Infectious Disease Testing Product Market Performance
9.9.4 BD Business Overview
9.9.5 BD Recent Developments
9.10 Bio-Rad Laboratories
9.10.1 Bio-Rad Laboratories Infectious Disease Testing Basic Information
9.10.2 Bio-Rad Laboratories Infectious Disease Testing Product Overview
9.10.3 Bio-Rad Laboratories Infectious Disease Testing Product Market Performance
9.10.4 Bio-Rad Laboratories Business Overview
9.10.5 Bio-Rad Laboratories Recent Developments
9.11 Cavidi
9.11.1 Cavidi Infectious Disease Testing Basic Information
9.11.2 Cavidi Infectious Disease Testing Product Overview
9.11.3 Cavidi Infectious Disease Testing Product Market Performance
9.11.4 Cavidi Business Overview
9.11.5 Cavidi Recent Developments
9.12 Cepheid
9.12.1 Cepheid Infectious Disease Testing Basic Information
9.12.2 Cepheid Infectious Disease Testing Product Overview
9.12.3 Cepheid Infectious Disease Testing Product Market Performance
9.12.4 Cepheid Business Overview
9.12.5 Cepheid Recent Developments
9.13 Chembio Diagnostic Systems
9.13.1 Chembio Diagnostic Systems Infectious Disease Testing Basic Information
9.13.2 Chembio Diagnostic Systems Infectious Disease Testing Product Overview
9.13.3 Chembio Diagnostic Systems Infectious Disease Testing Product Market Performance
9.13.4 Chembio Diagnostic Systems Business Overview
9.13.5 Chembio Diagnostic Systems Recent Developments
9.14 Clarity Diagnostics
9.14.1 Clarity Diagnostics Infectious Disease Testing Basic Information
9.14.2 Clarity Diagnostics Infectious Disease Testing Product Overview
9.14.3 Clarity Diagnostics Infectious Disease Testing Product Market Performance
9.14.4 Clarity Diagnostics Business Overview
9.14.5 Clarity Diagnostics Recent Developments
9.15 EMD Millipore
9.15.1 EMD Millipore Infectious Disease Testing Basic Information
9.15.2 EMD Millipore Infectious Disease Testing Product Overview
9.15.3 EMD Millipore Infectious Disease Testing Product Market Performance
9.15.4 EMD Millipore Business Overview
9.15.5 EMD Millipore Recent Developments
9.16 Epitope Diagnostic
9.16.1 Epitope Diagnostic Infectious Disease Testing Basic Information
9.16.2 Epitope Diagnostic Infectious Disease Testing Product Overview
9.16.3 Epitope Diagnostic Infectious Disease Testing Product Market Performance
9.16.4 Epitope Diagnostic Business Overview
9.16.5 Epitope Diagnostic Recent Developments
9.17 Gold Standard Diagnostics
9.17.1 Gold Standard Diagnostics Infectious Disease Testing Basic Information
9.17.2 Gold Standard Diagnostics Infectious Disease Testing Product Overview
9.17.3 Gold Standard Diagnostics Infectious Disease Testing Product Market Performance
9.17.4 Gold Standard Diagnostics Business Overview
9.17.5 Gold Standard Diagnostics Recent Developments
9.18 Hologic
9.18.1 Hologic Infectious Disease Testing Basic Information
9.18.2 Hologic Infectious Disease Testing Product Overview
9.18.3 Hologic Infectious Disease Testing Product Market Performance
9.18.4 Hologic Business Overview
9.18.5 Hologic Recent Developments
9.19 Immunetics
9.19.1 Immunetics Infectious Disease Testing Basic Information
9.19.2 Immunetics Infectious Disease Testing Product Overview
9.19.3 Immunetics Infectious Disease Testing Product Market Performance
9.19.4 Immunetics Business Overview
9.19.5 Immunetics Recent Developments
9.20 InBios International
9.20.1 InBios International Infectious Disease Testing Basic Information
9.20.2 InBios International Infectious Disease Testing Product Overview
9.20.3 InBios International Infectious Disease Testing Product Market Performance
9.20.4 InBios International Business Overview
9.20.5 InBios International Recent Developments
9.21 Life Technologies
9.21.1 Life Technologies Infectious Disease Testing Basic Information
9.21.2 Life Technologies Infectious Disease Testing Product Overview
9.21.3 Life Technologies Infectious Disease Testing Product Market Performance
9.21.4 Life Technologies Business Overview
9.21.5 Life Technologies Recent Developments
9.22 Maxim Biomedical
9.22.1 Maxim Biomedical Infectious Disease Testing Basic Information
9.22.2 Maxim Biomedical Infectious Disease Testing Product Overview
9.22.3 Maxim Biomedical Infectious Disease Testing Product Market Performance
9.22.4 Maxim Biomedical Business Overview
9.22.5 Maxim Biomedical Recent Developments
10 INFECTIOUS DISEASE TESTING MARKET FORECAST BY REGION
10.1 Global Infectious Disease Testing Market Size Forecast
10.2 Global Infectious Disease Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Infectious Disease Testing Market Size Forecast by Country
10.2.3 Asia Pacific Infectious Disease Testing Market Size Forecast by Region
10.2.4 South America Infectious Disease Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Infectious Disease Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Infectious Disease Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Infectious Disease Testing by Type (2025-2030)
11.1.2 Global Infectious Disease Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Infectious Disease Testing by Type (2025-2030)
11.2 Global Infectious Disease Testing Market Forecast by Application (2025-2030)
11.2.1 Global Infectious Disease Testing Sales (K Units) Forecast by Application
11.2.2 Global Infectious Disease Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Infectious Disease Testing
1.2 Key Market Segments
1.2.1 Infectious Disease Testing Segment by Type
1.2.2 Infectious Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Disease Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Infectious Disease Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Infectious Disease Testing Sales by Manufacturers (2019-2024)
3.2 Global Infectious Disease Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Infectious Disease Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Infectious Disease Testing Sales Sites, Area Served, Product Type
3.6 Infectious Disease Testing Market Competitive Situation and Trends
3.6.1 Infectious Disease Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Infectious Disease Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Infectious Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease Testing Sales Market Share by Type (2019-2024)
6.3 Global Infectious Disease Testing Market Size Market Share by Type (2019-2024)
6.4 Global Infectious Disease Testing Price by Type (2019-2024)
7 INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease Testing Market Sales by Application (2019-2024)
7.3 Global Infectious Disease Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
8 INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY REGION
8.1 Global Infectious Disease Testing Sales by Region
8.1.1 Global Infectious Disease Testing Sales by Region
8.1.2 Global Infectious Disease Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Infectious Disease Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Infectious Disease Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Infectious Disease Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Infectious Disease Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Infectious Disease Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Diagnostics
9.1.1 Abbott Diagnostics Infectious Disease Testing Basic Information
9.1.2 Abbott Diagnostics Infectious Disease Testing Product Overview
9.1.3 Abbott Diagnostics Infectious Disease Testing Product Market Performance
9.1.4 Abbott Diagnostics Business Overview
9.1.5 Abbott Diagnostics Infectious Disease Testing SWOT Analysis
9.1.6 Abbott Diagnostics Recent Developments
9.2 Abbott
9.2.1 Abbott Infectious Disease Testing Basic Information
9.2.2 Abbott Infectious Disease Testing Product Overview
9.2.3 Abbott Infectious Disease Testing Product Market Performance
9.2.4 Abbott Business Overview
9.2.5 Abbott Infectious Disease Testing SWOT Analysis
9.2.6 Abbott Recent Developments
9.3 Beckman Coulter Diagnostics
9.3.1 Beckman Coulter Diagnostics Infectious Disease Testing Basic Information
9.3.2 Beckman Coulter Diagnostics Infectious Disease Testing Product Overview
9.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Product Market Performance
9.3.4 Beckman Coulter Diagnostics Infectious Disease Testing SWOT Analysis
9.3.5 Beckman Coulter Diagnostics Business Overview
9.3.6 Beckman Coulter Diagnostics Recent Developments
9.4 Roche
9.4.1 Roche Infectious Disease Testing Basic Information
9.4.2 Roche Infectious Disease Testing Product Overview
9.4.3 Roche Infectious Disease Testing Product Market Performance
9.4.4 Roche Business Overview
9.4.5 Roche Recent Developments
9.5 Siemens Healthcare
9.5.1 Siemens Healthcare Infectious Disease Testing Basic Information
9.5.2 Siemens Healthcare Infectious Disease Testing Product Overview
9.5.3 Siemens Healthcare Infectious Disease Testing Product Market Performance
9.5.4 Siemens Healthcare Business Overview
9.5.5 Siemens Healthcare Recent Developments
9.6 Abaxis
9.6.1 Abaxis Infectious Disease Testing Basic Information
9.6.2 Abaxis Infectious Disease Testing Product Overview
9.6.3 Abaxis Infectious Disease Testing Product Market Performance
9.6.4 Abaxis Business Overview
9.6.5 Abaxis Recent Developments
9.7 Acon Laboratories
9.7.1 Acon Laboratories Infectious Disease Testing Basic Information
9.7.2 Acon Laboratories Infectious Disease Testing Product Overview
9.7.3 Acon Laboratories Infectious Disease Testing Product Market Performance
9.7.4 Acon Laboratories Business Overview
9.7.5 Acon Laboratories Recent Developments
9.8 Avioq
9.8.1 Avioq Infectious Disease Testing Basic Information
9.8.2 Avioq Infectious Disease Testing Product Overview
9.8.3 Avioq Infectious Disease Testing Product Market Performance
9.8.4 Avioq Business Overview
9.8.5 Avioq Recent Developments
9.9 BD
9.9.1 BD Infectious Disease Testing Basic Information
9.9.2 BD Infectious Disease Testing Product Overview
9.9.3 BD Infectious Disease Testing Product Market Performance
9.9.4 BD Business Overview
9.9.5 BD Recent Developments
9.10 Bio-Rad Laboratories
9.10.1 Bio-Rad Laboratories Infectious Disease Testing Basic Information
9.10.2 Bio-Rad Laboratories Infectious Disease Testing Product Overview
9.10.3 Bio-Rad Laboratories Infectious Disease Testing Product Market Performance
9.10.4 Bio-Rad Laboratories Business Overview
9.10.5 Bio-Rad Laboratories Recent Developments
9.11 Cavidi
9.11.1 Cavidi Infectious Disease Testing Basic Information
9.11.2 Cavidi Infectious Disease Testing Product Overview
9.11.3 Cavidi Infectious Disease Testing Product Market Performance
9.11.4 Cavidi Business Overview
9.11.5 Cavidi Recent Developments
9.12 Cepheid
9.12.1 Cepheid Infectious Disease Testing Basic Information
9.12.2 Cepheid Infectious Disease Testing Product Overview
9.12.3 Cepheid Infectious Disease Testing Product Market Performance
9.12.4 Cepheid Business Overview
9.12.5 Cepheid Recent Developments
9.13 Chembio Diagnostic Systems
9.13.1 Chembio Diagnostic Systems Infectious Disease Testing Basic Information
9.13.2 Chembio Diagnostic Systems Infectious Disease Testing Product Overview
9.13.3 Chembio Diagnostic Systems Infectious Disease Testing Product Market Performance
9.13.4 Chembio Diagnostic Systems Business Overview
9.13.5 Chembio Diagnostic Systems Recent Developments
9.14 Clarity Diagnostics
9.14.1 Clarity Diagnostics Infectious Disease Testing Basic Information
9.14.2 Clarity Diagnostics Infectious Disease Testing Product Overview
9.14.3 Clarity Diagnostics Infectious Disease Testing Product Market Performance
9.14.4 Clarity Diagnostics Business Overview
9.14.5 Clarity Diagnostics Recent Developments
9.15 EMD Millipore
9.15.1 EMD Millipore Infectious Disease Testing Basic Information
9.15.2 EMD Millipore Infectious Disease Testing Product Overview
9.15.3 EMD Millipore Infectious Disease Testing Product Market Performance
9.15.4 EMD Millipore Business Overview
9.15.5 EMD Millipore Recent Developments
9.16 Epitope Diagnostic
9.16.1 Epitope Diagnostic Infectious Disease Testing Basic Information
9.16.2 Epitope Diagnostic Infectious Disease Testing Product Overview
9.16.3 Epitope Diagnostic Infectious Disease Testing Product Market Performance
9.16.4 Epitope Diagnostic Business Overview
9.16.5 Epitope Diagnostic Recent Developments
9.17 Gold Standard Diagnostics
9.17.1 Gold Standard Diagnostics Infectious Disease Testing Basic Information
9.17.2 Gold Standard Diagnostics Infectious Disease Testing Product Overview
9.17.3 Gold Standard Diagnostics Infectious Disease Testing Product Market Performance
9.17.4 Gold Standard Diagnostics Business Overview
9.17.5 Gold Standard Diagnostics Recent Developments
9.18 Hologic
9.18.1 Hologic Infectious Disease Testing Basic Information
9.18.2 Hologic Infectious Disease Testing Product Overview
9.18.3 Hologic Infectious Disease Testing Product Market Performance
9.18.4 Hologic Business Overview
9.18.5 Hologic Recent Developments
9.19 Immunetics
9.19.1 Immunetics Infectious Disease Testing Basic Information
9.19.2 Immunetics Infectious Disease Testing Product Overview
9.19.3 Immunetics Infectious Disease Testing Product Market Performance
9.19.4 Immunetics Business Overview
9.19.5 Immunetics Recent Developments
9.20 InBios International
9.20.1 InBios International Infectious Disease Testing Basic Information
9.20.2 InBios International Infectious Disease Testing Product Overview
9.20.3 InBios International Infectious Disease Testing Product Market Performance
9.20.4 InBios International Business Overview
9.20.5 InBios International Recent Developments
9.21 Life Technologies
9.21.1 Life Technologies Infectious Disease Testing Basic Information
9.21.2 Life Technologies Infectious Disease Testing Product Overview
9.21.3 Life Technologies Infectious Disease Testing Product Market Performance
9.21.4 Life Technologies Business Overview
9.21.5 Life Technologies Recent Developments
9.22 Maxim Biomedical
9.22.1 Maxim Biomedical Infectious Disease Testing Basic Information
9.22.2 Maxim Biomedical Infectious Disease Testing Product Overview
9.22.3 Maxim Biomedical Infectious Disease Testing Product Market Performance
9.22.4 Maxim Biomedical Business Overview
9.22.5 Maxim Biomedical Recent Developments
10 INFECTIOUS DISEASE TESTING MARKET FORECAST BY REGION
10.1 Global Infectious Disease Testing Market Size Forecast
10.2 Global Infectious Disease Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Infectious Disease Testing Market Size Forecast by Country
10.2.3 Asia Pacific Infectious Disease Testing Market Size Forecast by Region
10.2.4 South America Infectious Disease Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Infectious Disease Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Infectious Disease Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Infectious Disease Testing by Type (2025-2030)
11.1.2 Global Infectious Disease Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Infectious Disease Testing by Type (2025-2030)
11.2 Global Infectious Disease Testing Market Forecast by Application (2025-2030)
11.2.1 Global Infectious Disease Testing Sales (K Units) Forecast by Application
11.2.2 Global Infectious Disease Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Disease Testing Market Size Comparison by Region (M USD)
Table 5. Global Infectious Disease Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Infectious Disease Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Infectious Disease Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Infectious Disease Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2022)
Table 10. Global Market Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Infectious Disease Testing Sales Sites and Area Served
Table 12. Manufacturers Infectious Disease Testing Product Type
Table 13. Global Infectious Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Infectious Disease Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Disease Testing Market Challenges
Table 22. Global Infectious Disease Testing Sales by Type (K Units)
Table 23. Global Infectious Disease Testing Market Size by Type (M USD)
Table 24. Global Infectious Disease Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Infectious Disease Testing Sales Market Share by Type (2019-2024)
Table 26. Global Infectious Disease Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Infectious Disease Testing Market Size Share by Type (2019-2024)
Table 28. Global Infectious Disease Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Infectious Disease Testing Sales (K Units) by Application
Table 30. Global Infectious Disease Testing Market Size by Application
Table 31. Global Infectious Disease Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Infectious Disease Testing Sales Market Share by Application (2019-2024)
Table 33. Global Infectious Disease Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Infectious Disease Testing Market Share by Application (2019-2024)
Table 35. Global Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Infectious Disease Testing Sales Market Share by Region (2019-2024)
Table 38. North America Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Diagnostics Infectious Disease Testing Basic Information
Table 44. Abbott Diagnostics Infectious Disease Testing Product Overview
Table 45. Abbott Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Diagnostics Business Overview
Table 47. Abbott Diagnostics Infectious Disease Testing SWOT Analysis
Table 48. Abbott Diagnostics Recent Developments
Table 49. Abbott Infectious Disease Testing Basic Information
Table 50. Abbott Infectious Disease Testing Product Overview
Table 51. Abbott Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abbott Business Overview
Table 53. Abbott Infectious Disease Testing SWOT Analysis
Table 54. Abbott Recent Developments
Table 55. Beckman Coulter Diagnostics Infectious Disease Testing Basic Information
Table 56. Beckman Coulter Diagnostics Infectious Disease Testing Product Overview
Table 57. Beckman Coulter Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Beckman Coulter Diagnostics Infectious Disease Testing SWOT Analysis
Table 59. Beckman Coulter Diagnostics Business Overview
Table 60. Beckman Coulter Diagnostics Recent Developments
Table 61. Roche Infectious Disease Testing Basic Information
Table 62. Roche Infectious Disease Testing Product Overview
Table 63. Roche Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Roche Business Overview
Table 65. Roche Recent Developments
Table 66. Siemens Healthcare Infectious Disease Testing Basic Information
Table 67. Siemens Healthcare Infectious Disease Testing Product Overview
Table 68. Siemens Healthcare Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Siemens Healthcare Business Overview
Table 70. Siemens Healthcare Recent Developments
Table 71. Abaxis Infectious Disease Testing Basic Information
Table 72. Abaxis Infectious Disease Testing Product Overview
Table 73. Abaxis Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Abaxis Business Overview
Table 75. Abaxis Recent Developments
Table 76. Acon Laboratories Infectious Disease Testing Basic Information
Table 77. Acon Laboratories Infectious Disease Testing Product Overview
Table 78. Acon Laboratories Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Acon Laboratories Business Overview
Table 80. Acon Laboratories Recent Developments
Table 81. Avioq Infectious Disease Testing Basic Information
Table 82. Avioq Infectious Disease Testing Product Overview
Table 83. Avioq Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Avioq Business Overview
Table 85. Avioq Recent Developments
Table 86. BD Infectious Disease Testing Basic Information
Table 87. BD Infectious Disease Testing Product Overview
Table 88. BD Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. BD Business Overview
Table 90. BD Recent Developments
Table 91. Bio-Rad Laboratories Infectious Disease Testing Basic Information
Table 92. Bio-Rad Laboratories Infectious Disease Testing Product Overview
Table 93. Bio-Rad Laboratories Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Bio-Rad Laboratories Business Overview
Table 95. Bio-Rad Laboratories Recent Developments
Table 96. Cavidi Infectious Disease Testing Basic Information
Table 97. Cavidi Infectious Disease Testing Product Overview
Table 98. Cavidi Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Cavidi Business Overview
Table 100. Cavidi Recent Developments
Table 101. Cepheid Infectious Disease Testing Basic Information
Table 102. Cepheid Infectious Disease Testing Product Overview
Table 103. Cepheid Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Cepheid Business Overview
Table 105. Cepheid Recent Developments
Table 106. Chembio Diagnostic Systems Infectious Disease Testing Basic Information
Table 107. Chembio Diagnostic Systems Infectious Disease Testing Product Overview
Table 108. Chembio Diagnostic Systems Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Chembio Diagnostic Systems Business Overview
Table 110. Chembio Diagnostic Systems Recent Developments
Table 111. Clarity Diagnostics Infectious Disease Testing Basic Information
Table 112. Clarity Diagnostics Infectious Disease Testing Product Overview
Table 113. Clarity Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Clarity Diagnostics Business Overview
Table 115. Clarity Diagnostics Recent Developments
Table 116. EMD Millipore Infectious Disease Testing Basic Information
Table 117. EMD Millipore Infectious Disease Testing Product Overview
Table 118. EMD Millipore Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. EMD Millipore Business Overview
Table 120. EMD Millipore Recent Developments
Table 121. Epitope Diagnostic Infectious Disease Testing Basic Information
Table 122. Epitope Diagnostic Infectious Disease Testing Product Overview
Table 123. Epitope Diagnostic Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Epitope Diagnostic Business Overview
Table 125. Epitope Diagnostic Recent Developments
Table 126. Gold Standard Diagnostics Infectious Disease Testing Basic Information
Table 127. Gold Standard Diagnostics Infectious Disease Testing Product Overview
Table 128. Gold Standard Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Gold Standard Diagnostics Business Overview
Table 130. Gold Standard Diagnostics Recent Developments
Table 131. Hologic Infectious Disease Testing Basic Information
Table 132. Hologic Infectious Disease Testing Product Overview
Table 133. Hologic Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Hologic Business Overview
Table 135. Hologic Recent Developments
Table 136. Immunetics Infectious Disease Testing Basic Information
Table 137. Immunetics Infectious Disease Testing Product Overview
Table 138. Immunetics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Immunetics Business Overview
Table 140. Immunetics Recent Developments
Table 141. InBios International Infectious Disease Testing Basic Information
Table 142. InBios International Infectious Disease Testing Product Overview
Table 143. InBios International Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. InBios International Business Overview
Table 145. InBios International Recent Developments
Table 146. Life Technologies Infectious Disease Testing Basic Information
Table 147. Life Technologies Infectious Disease Testing Product Overview
Table 148. Life Technologies Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Life Technologies Business Overview
Table 150. Life Technologies Recent Developments
Table 151. Maxim Biomedical Infectious Disease Testing Basic Information
Table 152. Maxim Biomedical Infectious Disease Testing Product Overview
Table 153. Maxim Biomedical Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Maxim Biomedical Business Overview
Table 155. Maxim Biomedical Recent Developments
Table 156. Global Infectious Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 157. Global Infectious Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 158. North America Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 159. North America Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 160. Europe Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 161. Europe Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 162. Asia Pacific Infectious Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 163. Asia Pacific Infectious Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 164. South America Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 165. South America Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 166. Middle East and Africa Infectious Disease Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 167. Middle East and Africa Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 168. Global Infectious Disease Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 169. Global Infectious Disease Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 170. Global Infectious Disease Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 171. Global Infectious Disease Testing Sales (K Units) Forecast by Application (2025-2030)
Table 172. Global Infectious Disease Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Disease Testing Market Size Comparison by Region (M USD)
Table 5. Global Infectious Disease Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Infectious Disease Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Infectious Disease Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Infectious Disease Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2022)
Table 10. Global Market Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Infectious Disease Testing Sales Sites and Area Served
Table 12. Manufacturers Infectious Disease Testing Product Type
Table 13. Global Infectious Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Infectious Disease Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Disease Testing Market Challenges
Table 22. Global Infectious Disease Testing Sales by Type (K Units)
Table 23. Global Infectious Disease Testing Market Size by Type (M USD)
Table 24. Global Infectious Disease Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Infectious Disease Testing Sales Market Share by Type (2019-2024)
Table 26. Global Infectious Disease Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Infectious Disease Testing Market Size Share by Type (2019-2024)
Table 28. Global Infectious Disease Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Infectious Disease Testing Sales (K Units) by Application
Table 30. Global Infectious Disease Testing Market Size by Application
Table 31. Global Infectious Disease Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Infectious Disease Testing Sales Market Share by Application (2019-2024)
Table 33. Global Infectious Disease Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Infectious Disease Testing Market Share by Application (2019-2024)
Table 35. Global Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Infectious Disease Testing Sales Market Share by Region (2019-2024)
Table 38. North America Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Infectious Disease Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Infectious Disease Testing Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Diagnostics Infectious Disease Testing Basic Information
Table 44. Abbott Diagnostics Infectious Disease Testing Product Overview
Table 45. Abbott Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Diagnostics Business Overview
Table 47. Abbott Diagnostics Infectious Disease Testing SWOT Analysis
Table 48. Abbott Diagnostics Recent Developments
Table 49. Abbott Infectious Disease Testing Basic Information
Table 50. Abbott Infectious Disease Testing Product Overview
Table 51. Abbott Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abbott Business Overview
Table 53. Abbott Infectious Disease Testing SWOT Analysis
Table 54. Abbott Recent Developments
Table 55. Beckman Coulter Diagnostics Infectious Disease Testing Basic Information
Table 56. Beckman Coulter Diagnostics Infectious Disease Testing Product Overview
Table 57. Beckman Coulter Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Beckman Coulter Diagnostics Infectious Disease Testing SWOT Analysis
Table 59. Beckman Coulter Diagnostics Business Overview
Table 60. Beckman Coulter Diagnostics Recent Developments
Table 61. Roche Infectious Disease Testing Basic Information
Table 62. Roche Infectious Disease Testing Product Overview
Table 63. Roche Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Roche Business Overview
Table 65. Roche Recent Developments
Table 66. Siemens Healthcare Infectious Disease Testing Basic Information
Table 67. Siemens Healthcare Infectious Disease Testing Product Overview
Table 68. Siemens Healthcare Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Siemens Healthcare Business Overview
Table 70. Siemens Healthcare Recent Developments
Table 71. Abaxis Infectious Disease Testing Basic Information
Table 72. Abaxis Infectious Disease Testing Product Overview
Table 73. Abaxis Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Abaxis Business Overview
Table 75. Abaxis Recent Developments
Table 76. Acon Laboratories Infectious Disease Testing Basic Information
Table 77. Acon Laboratories Infectious Disease Testing Product Overview
Table 78. Acon Laboratories Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Acon Laboratories Business Overview
Table 80. Acon Laboratories Recent Developments
Table 81. Avioq Infectious Disease Testing Basic Information
Table 82. Avioq Infectious Disease Testing Product Overview
Table 83. Avioq Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Avioq Business Overview
Table 85. Avioq Recent Developments
Table 86. BD Infectious Disease Testing Basic Information
Table 87. BD Infectious Disease Testing Product Overview
Table 88. BD Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. BD Business Overview
Table 90. BD Recent Developments
Table 91. Bio-Rad Laboratories Infectious Disease Testing Basic Information
Table 92. Bio-Rad Laboratories Infectious Disease Testing Product Overview
Table 93. Bio-Rad Laboratories Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Bio-Rad Laboratories Business Overview
Table 95. Bio-Rad Laboratories Recent Developments
Table 96. Cavidi Infectious Disease Testing Basic Information
Table 97. Cavidi Infectious Disease Testing Product Overview
Table 98. Cavidi Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Cavidi Business Overview
Table 100. Cavidi Recent Developments
Table 101. Cepheid Infectious Disease Testing Basic Information
Table 102. Cepheid Infectious Disease Testing Product Overview
Table 103. Cepheid Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Cepheid Business Overview
Table 105. Cepheid Recent Developments
Table 106. Chembio Diagnostic Systems Infectious Disease Testing Basic Information
Table 107. Chembio Diagnostic Systems Infectious Disease Testing Product Overview
Table 108. Chembio Diagnostic Systems Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Chembio Diagnostic Systems Business Overview
Table 110. Chembio Diagnostic Systems Recent Developments
Table 111. Clarity Diagnostics Infectious Disease Testing Basic Information
Table 112. Clarity Diagnostics Infectious Disease Testing Product Overview
Table 113. Clarity Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Clarity Diagnostics Business Overview
Table 115. Clarity Diagnostics Recent Developments
Table 116. EMD Millipore Infectious Disease Testing Basic Information
Table 117. EMD Millipore Infectious Disease Testing Product Overview
Table 118. EMD Millipore Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. EMD Millipore Business Overview
Table 120. EMD Millipore Recent Developments
Table 121. Epitope Diagnostic Infectious Disease Testing Basic Information
Table 122. Epitope Diagnostic Infectious Disease Testing Product Overview
Table 123. Epitope Diagnostic Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Epitope Diagnostic Business Overview
Table 125. Epitope Diagnostic Recent Developments
Table 126. Gold Standard Diagnostics Infectious Disease Testing Basic Information
Table 127. Gold Standard Diagnostics Infectious Disease Testing Product Overview
Table 128. Gold Standard Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Gold Standard Diagnostics Business Overview
Table 130. Gold Standard Diagnostics Recent Developments
Table 131. Hologic Infectious Disease Testing Basic Information
Table 132. Hologic Infectious Disease Testing Product Overview
Table 133. Hologic Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Hologic Business Overview
Table 135. Hologic Recent Developments
Table 136. Immunetics Infectious Disease Testing Basic Information
Table 137. Immunetics Infectious Disease Testing Product Overview
Table 138. Immunetics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Immunetics Business Overview
Table 140. Immunetics Recent Developments
Table 141. InBios International Infectious Disease Testing Basic Information
Table 142. InBios International Infectious Disease Testing Product Overview
Table 143. InBios International Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. InBios International Business Overview
Table 145. InBios International Recent Developments
Table 146. Life Technologies Infectious Disease Testing Basic Information
Table 147. Life Technologies Infectious Disease Testing Product Overview
Table 148. Life Technologies Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Life Technologies Business Overview
Table 150. Life Technologies Recent Developments
Table 151. Maxim Biomedical Infectious Disease Testing Basic Information
Table 152. Maxim Biomedical Infectious Disease Testing Product Overview
Table 153. Maxim Biomedical Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Maxim Biomedical Business Overview
Table 155. Maxim Biomedical Recent Developments
Table 156. Global Infectious Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 157. Global Infectious Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 158. North America Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 159. North America Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 160. Europe Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 161. Europe Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 162. Asia Pacific Infectious Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 163. Asia Pacific Infectious Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 164. South America Infectious Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 165. South America Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 166. Middle East and Africa Infectious Disease Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 167. Middle East and Africa Infectious Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 168. Global Infectious Disease Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 169. Global Infectious Disease Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 170. Global Infectious Disease Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 171. Global Infectious Disease Testing Sales (K Units) Forecast by Application (2025-2030)
Table 172. Global Infectious Disease Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Infectious Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease Testing Market Size (M USD), 2019-2030
Figure 5. Global Infectious Disease Testing Market Size (M USD) (2019-2030)
Figure 6. Global Infectious Disease Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease Testing Market Size by Country (M USD)
Figure 11. Infectious Disease Testing Sales Share by Manufacturers in 2023
Figure 12. Global Infectious Disease Testing Revenue Share by Manufacturers in 2023
Figure 13. Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Infectious Disease Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Infectious Disease Testing Market Share by Type
Figure 18. Sales Market Share of Infectious Disease Testing by Type (2019-2024)
Figure 19. Sales Market Share of Infectious Disease Testing by Type in 2023
Figure 20. Market Size Share of Infectious Disease Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Infectious Disease Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Infectious Disease Testing Market Share by Application
Figure 24. Global Infectious Disease Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Infectious Disease Testing Sales Market Share by Application in 2023
Figure 26. Global Infectious Disease Testing Market Share by Application (2019-2024)
Figure 27. Global Infectious Disease Testing Market Share by Application in 2023
Figure 28. Global Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Infectious Disease Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Infectious Disease Testing Sales Market Share by Country in 2023
Figure 32. U.S. Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Infectious Disease Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Infectious Disease Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Infectious Disease Testing Sales Market Share by Country in 2023
Figure 37. Germany Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Infectious Disease Testing Sales Market Share by Region in 2023
Figure 44. China Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 50. South America Infectious Disease Testing Sales Market Share by Country in 2023
Figure 51. Brazil Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Infectious Disease Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Infectious Disease Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Infectious Disease Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Infectious Disease Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Infectious Disease Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Infectious Disease Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Infectious Disease Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Infectious Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease Testing Market Size (M USD), 2019-2030
Figure 5. Global Infectious Disease Testing Market Size (M USD) (2019-2030)
Figure 6. Global Infectious Disease Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease Testing Market Size by Country (M USD)
Figure 11. Infectious Disease Testing Sales Share by Manufacturers in 2023
Figure 12. Global Infectious Disease Testing Revenue Share by Manufacturers in 2023
Figure 13. Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Infectious Disease Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Infectious Disease Testing Market Share by Type
Figure 18. Sales Market Share of Infectious Disease Testing by Type (2019-2024)
Figure 19. Sales Market Share of Infectious Disease Testing by Type in 2023
Figure 20. Market Size Share of Infectious Disease Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Infectious Disease Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Infectious Disease Testing Market Share by Application
Figure 24. Global Infectious Disease Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Infectious Disease Testing Sales Market Share by Application in 2023
Figure 26. Global Infectious Disease Testing Market Share by Application (2019-2024)
Figure 27. Global Infectious Disease Testing Market Share by Application in 2023
Figure 28. Global Infectious Disease Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Infectious Disease Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Infectious Disease Testing Sales Market Share by Country in 2023
Figure 32. U.S. Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Infectious Disease Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Infectious Disease Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Infectious Disease Testing Sales Market Share by Country in 2023
Figure 37. Germany Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Infectious Disease Testing Sales Market Share by Region in 2023
Figure 44. China Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 50. South America Infectious Disease Testing Sales Market Share by Country in 2023
Figure 51. Brazil Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Infectious Disease Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Infectious Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Infectious Disease Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Infectious Disease Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Infectious Disease Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Infectious Disease Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Infectious Disease Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Infectious Disease Testing Market Share Forecast by Application (2025-2030)
